(HealthDay News) — For patients undergoing elective carotid artery stenting (CAS), stroke/death rates are similar with use of proximal embolic protection devices (P-EPDs) and distal filter embolic ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Elective carotid artery angioplasty and stenting was initiated in the United States in 1994 by the endovascular interventional team at the University of Alabama at Birmingham. Carotid stenting was ...

"The reasons for these findings likely represent our lack of a complete understanding of the factors involved in no-reflow/distal embolization phenomena." The use of a distal embolic protection device ...

€2.1M Grant to support Filterlex's CAPTIS clinical trials YOKNEAM, Israel, Sept. 16, 2019 /PRNewswire/ -- Filterlex Medical, an innovative medical device startup in the cardiovascular field, today ...

United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...

Illustration of a sinusoidal thrombus capture wire positioned between two expandable spheres, designed for effective clot removal in vascular procedures. The distal sphere expands to anchor and ...

DUBLIN, April 18, 2023 /PRNewswire/ -- The "Embolic Protection Device Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been ...

(MENAFN- EIN Presswire) EINPresswire/ -- The Embolic Protection Devices Market is gaining significant traction globally, driven by the rising prevalence of cardiovascular diseases, increasing adoption ...